miR-155 in cancer drug resistance and as target for miRNA-based therapeutics

Recep Bayraktar1, Katrien Van Roosbroeck2

  • 1Department of Experimental Therapeutics, The University of Texas MD Anderson Cancer Center, 1881 Holcombe Boulevard, Unit 1950, Houston, TX, 77054, USA.

Cancer Metastasis Reviews
|December 29, 2017
PubMed

Insights

MicroRNAs (miRNAs) regulate cell processes, with miR-155 linked to cancer and therapy resistance. Targeting miR-155 offers potential for novel cancer treatments.

Area of Science:

  • Molecular Biology
  • Oncology
  • Immunology

Background:

  • MicroRNAs (miRNAs) are key regulators of cellular functions, including proliferation and apoptosis.
  • Dysregulated miRNA expression is implicated in various diseases, notably cancer.
  • miR-155 is a conserved, multifunctional miRNA frequently overexpressed in malignant tumors.

Purpose of the Study:

  • To review the role of miR-155 in hematopoietic differentiation, immune response, and inflammation.
  • To explore miR-155's involvement in cancer therapy resistance.
  • To discuss the therapeutic potential of targeting miR-155 in cancer treatment.

Main Methods:

  • Literature review of studies on miR-155 function and its clinical relevance.
  • Analysis of miR-155's impact on cellular processes and disease pathogenesis.
  • Synthesis of current knowledge on miR-155-mediated signaling pathways.

Main Results:

  • miR-155 is associated with hematopoietic lineage differentiation, immune regulation, and inflammatory processes.
  • Overexpression of miR-155 contributes to tumorigenesis and drives therapy resistance in various cancers.
  • miR-155 plays a significant role in the complex interplay between immunity, inflammation, and cancer development.

Conclusions:

  • miR-155 is a critical regulator in physiological and pathological processes, particularly in cancer.
  • Understanding miR-155's functions is crucial for developing targeted cancer therapies.
  • miR-155-based strategies hold promise for overcoming cancer therapy resistance and improving patient outcomes.

Related Concept Videos

Cardiovascular Drugs: Classification based on Therapeutic Indications01:18

Cardiovascular Drugs: Classification based on Therapeutic Indications

Cardiovascular diseases, encompassing a range of conditions, can significantly affect the heart's operations and the overall circulatory system. These conditions impair the heart's ability to pump blood, leading to a deficit in oxygen supply to crucial organs. Anomalies in the heart's electrical system, known as arrhythmias, can cause heartbeats to accelerate or slow down. Usually, heart rates increase during physical activity and decrease while resting or sleeping. However,...
4.3K
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.8K
Antipsychotic Drugs: Therapeutic Uses and Side Effects01:21

Antipsychotic Drugs: Therapeutic Uses and Side Effects

Antipsychotic drugs primarily block dopamine and serotonin receptors and cholinergic, adrenergic, and histaminergic receptors, thereby reducing hallucinations and delusions in conditions like schizophrenia. However, they can trigger unwanted extrapyramidal effects such as dystonias, Parkinson-like symptoms, and tardive dyskinesia.
Despite these side effects, antipsychotics are used therapeutically for various purposes, including managing schizophrenia, preventing nausea and vomiting, curbing...
864
Therapeutic Drug Monitoring: Drug Analysis Methods01:26

Therapeutic Drug Monitoring: Drug Analysis Methods

Therapeutic Drug Monitoring (TDM) is a clinical practice that measures specific drug levels in a patient's blood or body tissues to tailor drug therapy effectively. This monitoring is critical for managing drugs with narrow therapeutic indices like digoxin and phenytoin, ensuring they are both safe and effective. For instance, monitoring theophylline levels in asthma patients involves precision and sensitivity to adjust doses according to individual responses to therapy, ensuring efficacy and...
216
Therapeutic Drug Monitoring: Affecting Factors01:29

Therapeutic Drug Monitoring: Affecting Factors

Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.
256
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
9.0K